We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+17.7%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.06%
5 Year Est. Return
+670.57%
10 Year Est. Return
–
AUM
$956M
AUM Growth
-$88.9M
Cap. Flow
-$124M
Cap. Flow %
-13%
Top 10 Hldgs %
51.28%
Holding
904
New
257
Increased
162
Reduced
180
Closed
232

Top Buys

Rank Stock Value
1
DCP
DCP Midstream, LP
DCP
+$58.7M
2
IMVT icon
Immunovant
IMVT
+$15.7M
3
LL
LL Flooring Holdings, Inc.
LL
+$11.4M
4
ACET icon
Adicet Bio
ACET
+$10.9M
5
INVZ icon
Innoviz Technologies
INVZ
+$9.95M

Top Sells

Rank Stock Value
1
ARKK icon
ARK Innovation ETF
ARKK
+$131M
2
IMCR icon
Immunocore
IMCR
+$34.1M
3
FTAI icon
FTAI Aviation
FTAI
+$28.1M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$20.8M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$14.4M

Sector Composition

Rank Sector Weight
1 Healthcare 36.98%
2 Financials 14.53%
3 Materials 10.99%
4 Energy 8.52%
5 Consumer Discretionary 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLVM icon
1
Sylvamo
SLVM
$1.49B
$104M 10.92%
2,150,000
– –
RNAM
2
DELISTED
Avidity Biosciences
RNAM
$95.2M 9.95%
4,288,366
+500,000
+13% +$7.46M
DCP
3
DELISTED
DCP Midstream, LP
DCP
$58.8M 6.15%
+1,516,562
New +$58.7M
ESTA icon
4
Establishment Labs
ESTA
$2.75B
$56.2M 5.88%
856,654
+20,000
+2% +$1.21M
CUTR
5
DELISTED
Cutera, Inc.
CUTR
$29.7M 3.1%
671,309
+75,096
+13% +$3.42M
INVZ icon
6
Innoviz Technologies
INVZ
$93.2M
$28.1M 2.94%
7,156,390
+2,090,000
+41% +$9.95M
ACET icon
7
Adicet Bio
ACET
$84.7M
$28.1M 2.94%
196,476
+43,773
+29% +$10.9M
SMFG icon
8
Sumitomo Mitsui Financial
SMFG
$164B
$27M 2.83%
3,370,730
-306,375
-8% -$1.95M
AVDL
9
DELISTED
Avadel Pharmaceuticals
AVDL
$26.7M 2.79%
3,732,778
– –
SCPL
10
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
$24.9M 2.61%
1,551,246
+80,000
+5% +$1.16M
IMCR icon
11
Immunocore
IMCR
$1.72B
$23.1M 2.42%
405,174
-606,496
-60% -$34.1M
IMVT icon
12
Immunovant
IMVT
$8.11B
$22.2M 2.32%
+1,250,000
New +$15.7M
RCKT icon
13
Rocket Pharmaceuticals
RCKT
$351M
$21.5M 2.25%
1,100,000
+100,412
+10% +$1.85M
ET icon
14
Energy Transfer Partners
ET
$69.6B
$20.4M 2.13%
1,715,000
-160,000
-9% -$1.92M
PEGR
15
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
$15.1M 1.58%
1,500,000
– –
HCVIU
16
DELISTED
Hennessy Capital Investment Corp. VI Unit
HCVIU
$14.8M 1.54%
1,500,000
– –
CTLP
17
DELISTED
Cantaloupe
CTLP
$12.3M 1.28%
2,821,409
-1,033,831
-27% -$3.67M
FULC icon
18
Fulcrum Therapeutics
FULC
$248M
$9.91M 1.04%
1,361,169
-986,820
-42% -$6.44M
ODP
19
DELISTED
ODP
ODP
$9.3M 0.97%
204,181
-5,500
-3% -$235K
MSOS icon
20
AdvisorShares Pure US Cannabis ETF
MSOS
$854M
$9.25M 0.97%
1,323,344
+212,900
+19% +$2.19M
LL
21
DELISTED
LL Flooring Holdings, Inc.
LL
$9.12M 0.95%
+1,622,000
New +$11.4M
KAIR
22
DELISTED
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
$8.76M 0.92%
+869,000
New +$8.72M
NSTC
23
DELISTED
Northern Star Investment Corp. III
NSTC
$7.39M 0.77%
+735,000
New +$7.32M
ALPAU
24
DELISTED
Alpha Healthcare Acquisition Corp III Units
ALPAU
$6.99M 0.73%
700,000
– –
STOK icon
25
Stoke Therapeutics
STOK
$1.87B
$6.9M 0.72%
748,077
-21,092
-3% -$219K
1
2 3 4 5

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q4 2022 Portfolio in Review

As of Q4 2022, Cowen and Company held 904 positions worth $956M, down 8.5% from $1.05B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Cowen and Company withdrew a net $124M in Q4 2022, closing 232 positions and reducing 180 holdings. Its most notable exit was ARK Innovation ETF, an estimated $131M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 34% a quarter earlier, followed by Financials and Materials.

Against the trend, Cowen and Company opened a new position in DCP Midstream, LP worth $58.8M.

  • Cowen and Company's largest Q4 2022 buy was DCP Midstream, LP: 1,516,562 shares worth $58.8M.
  • Cowen and Company added most to Adicet Bio in Q4 2022, an estimated $10.9M increase.
  • Cowen and Company's biggest Q4 2022 reduction was Immunocore, cutting an estimated $34.1M.
  • Cowen and Company fully exited ARK Innovation ETF in Q4 2022, selling an estimated $131M.
  • Cowen and Company's ten largest holdings make up 51% of its $956M portfolio in Q4 2022.
  • Cowen and Company opened 257 new positions and closed 232 in Q4 2022.
  • Cowen and Company's portfolio value fell 8.5% quarter-over-quarter to $956M.

Based on Cowen and Company's 13F filing for Q4 2022, filed 9 Feb 2023.